Exp Clin Endocrinol Diabetes 2010; 118(10): 747-753
DOI: 10.1055/s-0030-1253413
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Sepsis and Cardiomyopathy as Rare Clinical Manifestations of Pheochromocytoma – Two Case Report Studies

Y. Tanriver1 , 5 , 6 , M. J. Betz3 , 6 , L. Nibbe1 , T. Pfluger4 , F. Beuschlein3 , M. Z.  Strowski2
  • 1Department of Nephrology and Medical Intensive Care
  • 2Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin
  • 3Department of Endocrine Research Unit, Medizinische Klinik-Innenstadt
  • 4Department of Nuclear Medicine, Klinikum der Ludwig-Maximilians-Universität, München
  • 5Department of Renal Division, Department of Medicine, University Hospital Freiburg, Freiburg, Germany
  • 6both authors equally contributed to the work
Weitere Informationen

Publikationsverlauf

received 11.12.2009 first decision 24.02.2010

accepted 15.04.2010

Publikationsdatum:
10. Juni 2010 (online)

Abstract

The clinical manifestation of pheochromocytomas is highly variable and can closely resemble numerous clinical conditions. Here, we report on two cases of patients with pheochromocytoma, which manifested as sepsis or cardiomyopathy. The first patient initially presented with bacterial urosepsis due to klebsiella oxytoca. Despite effective antibiotic therapy, the patient developed recurring fever accompanied by hypertension. The inconsistency between therapy-refractory hypertension and fever indicated the possibility of excessive catecholamine production. In the second case, the patient presented with a suspected ST-segment elevation myocardial infarction accompanied by E. coli sepsis and a previously undiagnosed unilateral tumor mass of the adrenal gland. Severely impaired myocardial contraction of the apical anterior and inferior regions without significant coronary artery disease was consistent with the Takotsubo cardiomyopathy, a known transient functional myocardial complication associated with pheochromocytoma. Both patients were diagnosed with unilateral pheochromocytoma. Following pre-operative antihypertensive therapy, both patients were cured by surgery and still remain free of disease after two years of follow-up.

References

  • 1 Whalen RK, Althausen AF, Daniels GH. Extra-adrenal pheochromocytoma.  J Urol. 1992;  147 1-10
  • 2 Pacak K, Linehan WM, Eisenhofer G. et al . Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.  Ann Intern Med. 2001;  134 315-329
  • 3 McNeil AR, Blok BH, Koelmeyer TD. et al . Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland.  Aust N Z J Med. 2000;  30 648-652
  • 4 Eisenhofer G, Bornstein SR, Brouwers FM. et al . Malignant pheochromocytoma: current status and initiatives for future progress.  Endocr Relat Cancer. 2004;  11 423-436
  • 5 Omura M, Saito J, Yamaguchi K. et al . Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.  Hypertens Res. 2004;  27 193-202
  • 6 Anderson Jr GH, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients.  J Hypertens. 1994;  12 609-615
  • 7 Sinclair AM, Isles CG, Brown I. et al . Secondary hypertension in a blood pressure clinic.  Arch Intern Med. 1987;  147 1289-1293
  • 8 Lenders JW, Eisenhofer G, Mannelli M. et al . Phaeochromocytoma.  Lancet. 2005;  366 665-675
  • 9 Neumann HP, Berger DP, Sigmund G. et al . Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.  N Engl J Med. 1993;  329 1531-1538
  • 10 Adler JT, Meyer-Rochow GY, Chen H. et al . Pheochromocytoma: current approaches and future directions.  Oncologist. 2008;  13 779-793
  • 11 Brouwers FM, Lenders JW, Eisenhofer G. et al . Pheochromocytoma as an endocrine emergency.  Rev Endocr Metab Disord. 2003;  4 121-128
  • 12 Ueda T, Oka N, Matsumoto A. et al . Pheochromocytoma presenting as recurrent hypotension and syncope.  Intern Med. 2005;  44 222-227
  • 13 La Batide-Alanore A, Chatellier G, Plouin PF. Diabetes as a marker of pheochromocytoma in hypertensive patients.  J Hypertens. 2003;  21 1703-1707
  • 14 Mannelli M, Ianni L, Cilotti A. et al . Pheochromocytoma in Italy: a multicentric retrospective study.  Eur J Endocrinol. 1999;  141 619-624
  • 15 Newell KA, Prinz RA, Pickleman J. et al . Pheochromocytoma multisystem crisis. A surgical emergency.  Arch Surg. 1988;  123 956-959
  • 16 Boulkina LS, Newton CA, Drake III AJ. et al . Acute myocardial infarction attributable to adrenergic crises in a patient with pheochromocytoma and neurofibromatosis 1.  Endocr Pract. 2007;  13 269-273
  • 17 Salahuddin A, Rohr-Kirchgraber T, Shekar R. et al . Interleukin-6 in the fever and multiorgan crisis of pheochromocytoma.  Scand J Infect Dis. 1997;  29 640-642
  • 18 Ehrhart-Bornstein M, Hinson JP, Bornstein SR. et al . Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.  Endocr Rev. 1998;  19 101-143
  • 19 Tischler AS, Perlman RL, Morse GM. et al . Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell cultures.  J Neurochem. 1983;  40 364-370
  • 20 Hoen S, Mazoit JX, Asehnoune K. et al . Hydrocortisone increases the sensitivity to alpha1-adrenoceptor stimulation in humans following hemorrhagic shock.  Crit Care Med. 2005;  33 2737-2743
  • 21 Mayfield KP, Soszynski D, Kozak W. et al . Beta-adrenergic receptor subtype effects on stress fever and thermoregulation.  Neuroimmunomodulation. 1999;  6 305-317
  • 22 Blaak EE, van Baak MA, Kempen KP. et al . Role of alpha- and beta-adrenoceptors in sympathetically mediated thermogenesis.  Am J Physiol. 1993;  264 E11-E17
  • 23 Schiffelers SL, Blaak EE, Saris WH. et al . In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.  Clin Pharmacol Ther. 2000;  67 558-566
  • 24 Pacak K, Eisenhofer G, Ahlman H. et al . Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.  Nat Clin Pract Endocrinol Metab. 2007;  3 92-102
  • 25 Soares-Filho GL, Felix RC, Azevedo JC. et al . Broken Heart or Takotsubo Syndrome: Support for the neurohumoral hypothesis of stress cardiomyopathy.  Prog Neuropsychopharmacol Biol Psychiatry. 2009; 
  • 26 Donohue D, Movahed MR. Clinical characteristics, demographics and prognosis of transient left ventricular apical ballooning syndrome.  Heart Fail Rev. 2005;  10 311-316
  • 27 Takizawa M, Kobayakawa N, Uozumi H. et al . A case of transient left ventricular ballooning with pheochromocytoma, supporting pathogenetic role of catecholamines in stress-induced cardiomyopathy or takotsubo cardiomyopathy.  Int J Cardiol. 2007;  114 e15-e17
  • 28 Verrijcken A, Sciot R, Dubois CL. From trivial headache to life-threatening disease.  Int J Cardiol. 2009; 
  • 29 Turley A, Graham R, Hall J. Takotsubo cardiomyopathy in two female patients: two case reports.  Cases J. 2008;  1 325
  • 30 Kalra PA, Thornton-Chan EW, Weinkove C. et al . Phaeochromocytoma presenting with acute intestinal ischaemia and shock.  Postgrad Med J. 1990;  66 982
  • 31 Maguire BM, Edwards ML, Breheny FX. Ischaemic enterocolitis: an unusual presentation of phaeochromocytoma.  Med J Aust. 1991;  154 567-568
  • 32 Salehi A, Legome EL, Eichhorn K. et al . Pheochromocytoma and bowel ischemia.  J Emerg Med. 1997;  15 35-38
  • 33 Karri V, Khan SL, Wilson Y. Bowel perforation as a presenting feature of pheochromocytoma: case report and literature review.  Endocr Pract. 2005;  11 385-388
  • 34 Karagiannis A, Mikhailidis DP, Athyros VG. et al . Pheochromocytoma: an update on genetics and management.  Endocr Relat Cancer. 2007;  14 935-956
  • 35 Jimenez C, Cote G, Arnold A. et al . Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?.  J Clin Endocrinol Metab. 2006;  91 2851-2858
  • 36 Proye C, Thevenin D, Cecat P. et al . Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients.  Surgery. 1989;  106 1149-1154
  • 37 Walther MM. New therapeutic and surgical approaches for sporadic and hereditary pheochromocytoma.  Ann N Y Acad Sci. 2002;  970 41-53
  • 38 Steinsapir J, Carr AA, Prisant LM. et al . Metyrosine and pheochromocytoma.  Arch Intern Med. 1997;  157 901-906

Correspondence

M. Z. StrowskiMD 

Medizinische Klinik m. S.

Hepatologie

Gastroenterologie &

Interdisziplinäres Stoffwechsel-

Centrum/Endokrinologie und

Diabetes mellitus

Charité-Universitätsmedizin

Berlin

Campus Virchow-

Klinikum

Augustenburger Platz 1

13353 Berlin

Germany

Telefon: +49/030/450 559 066

Fax: +49/030/450 559 966

eMail: mathias.strowski@charite.de

    >